XINT Share Price Performance
SEK 0.48
-0.02 (-3.64%)
Price SEK 0.48
Share PriceSEK 0.48
Xintela AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
XINT Community Narratives
There are no narratives available yet.
Recent XINT News & Updates
Xintela AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 21, 2025
- Earnings per share (EPS)
- -0.058
- Gross Margin
- 100.00%
- Net Profit Margin
- -824.29%
- Debt/Equity Ratio
- 0%
Xintela AB (publ) Competitors
Snowflake Analysis
About XINT
- Founded
- 2009
- Employees
- 13
- CEO
- WebsiteView website
Xintela AB (publ), a biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy. The company’s stem cell products include XSTEM, which is in Phase I/IIa clinical development for the treatment of knee osteoarthritis, as well as in clinical study for the treatment of difficult-to-heal leg ulcers, acute respiratory distress syndrome, and other indications; and EQSTEM that is in preclinical development for the treatment of joint disease in horses. It is also developing antibody-based cancer therapies, such as TARG9 and TARG10, which are in preclinical study for the treatment of triple-negative breast cancer and the brain tumor glioblastoma. It has an agreement with Region Östergötland for GMP process development of cell therapy for burn patients. Xintela AB (publ) was incorporated in 2009 and is based in Lund, Sweden.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Swedish Market Performance
- 7 Days: -1.1%
- 3 Months: 1.8%
- 1 Year: -1.3%
- Year to Date: 2.0%
Over the last 7 days, the market has dropped 1.1%, driven by a loss of 1.7% in the Industrials sector. Overall the market has been flat in the last year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›